The Food and Drug Administration (FDA) has submitted to the Bureau of Internal Revenue (BIR) an additional list of medicines used for the treatment of five serious illnesses which are exempted from the 12 percent value-added tax (VAT).
The generic names of these medicines included: Ibandronic (Ac